Crinetics Pharmaceuticals, Inc. CRNX
- atumelnant — Congenital Adrenal Hyperplasia Phase 3
- atumelnant — ACTH-Dependent Cushing's Syndrome Phase 1
MC2R (1 companies · 2 programs)
Companies with an active program directed at MC2R.
Companies with an active program directed at MC2R.